comparemela.com

Latest Breaking News On - Qiming venture partners - Page 21 : comparemela.com

TandemAI Raises $35M in Series A Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Kan chenNew york basedQiming venture partnersEight roads ventures

Oricell Therapeutics: Oricell Closes $45M Series B1 Financing to Expand Development of Key Products

SHANGHAI, Feb. 28, 2023 /PRNewswire/ Oricell Therapeutics Co., Ltd ("Oricell" or "the Company"), a China-based innovative pharmaceutical company committed to the development of tumor cellular

New yorkUnited statesHong kongCity ofUnited kingdomState of qatarDennis riedlBroderick wongHelen yangAmerican society of clinical oncologyXiamencd corporationPrnewswire oricell therapeutics co ltdQatar investment authorityEuropean hematology associationQiming venture partnersClinical oncology

Oricell Closes $45M Series B1 Financing to Expand Development of Key Products

/PRNewswire/ Oricell Therapeutics Co., Ltd ("Oricell" or "the Company"), a China-based innovative pharmaceutical company committed to the development of.

New yorkUnited statesHong kongCity ofUnited kingdomState of qatarBroderick wongHelen yangAmerican society of clinical oncologyXiamencd corporationPrnewswire oricell therapeutics co ltdQatar investment authorityEuropean hematology associationQiming venture partnersClinical oncologyAnnual meeting

Oricell Closes $45M Series B1 Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Helen yangQatar investment authorityOricell therapeuticsQiming venture partners

Qiming-backed drugmaker Oricell raises $45m to advance pipeline in US

The new financing is an extension of Oricell's $125-million Series B round that it closed in July 2022.

New yorkUnited statesCity ofUnited kingdomState of qatarBroderick wongSuzhou fundQatar investment authorityOricell therapeuticsQiming venture partnersQuan capitalSinopharm capitalSeries pre aInvestigational new drugMagnolia medical

vimarsana © 2020. All Rights Reserved.